3 results
Approved WMOCompleted
The aim of this Phase II proof of concept study is to assess efficacy, haemodynamics and safety of Terguride vs. placebo in patients with pulmonary arterial hypertension (PAH). Having finished this proof-of-concept study it is intended that patients…
Approved WMOCompleted
To determine whether a second IVIg course in GBS patients with a poor prognosis improves functional outcome after 4 weeks.
Approved WMOCompleted
Safety and feasibility of IRE for PVI